Bristol-Myers Squibb Co (BMS) which is a global biopharmaceutical company that discovers, develops, license, manufacture, sell and distribute medicines to patients. Its main focus is on cancer, cardiovascular, immunology, and virology therapeutic projects. (Ref. BMS website)

SWOT Analysis:
1. Strengths:
– Innovation
– Strong focus on Research and development
– High ranking among medical devices companies (#14 globally per Pharmaceutical Executive – 2018)
– Successful strategic investment in healthcare business and medical devices marketing
– High level of customer satisfaction

2. Weaknesses:
– Investment in Research and Development is not as fast as other growing companies in the healthcare industry
– Not very strong in integrating firms with different work cultures
– Gaps in the product range
– Weak presence in biologics division

3. Opportunities:
– New customers from the online channel
– Different pricing strategy can be followed using new technologies
– The growing biologic therapy cancer market
– The growth and development in biopharmaceutical companies which means the opportunity for more new agreements
– A new era of digital technology for healthcare transformation

4. Threats:
– Changes in FDA or US rules or regulations
– Changes in financial conditions
– The high competition in the healthcare industry
– The need for highly profitable products is seasonal

(Ref. fernfortuniversity & swotandpestle websites)